DEA Relents, Will Identify High-Volume Opiate Drug Makers, Distributers
CLEVELAND — The U.S. Drug Enforcement Agency (DEA) on March 5 told the opioid multidistrict litigation court that it will produce information identifying drug companies and distributors that sold 95 percent...To view the full article, register now.
Already a subscriber? Click here to view full article